We previously reported that the extracellular domain of SDC2 interacts with the MMP-7 pro-domain [32], and that a synthetic peptide corresponding to a portion of the human SDC2 sequence (S2-P) bound to the pro-domain of MMP-7 and inhibited SDC2-mediated cancer activities [11]. This evidence concerns the gene MMP7 and cancer.